SCHEMBL8211206

SCHEMBL8211206

NC(=O)[C@@H](N)CSCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 2/20 0.48
▸ HIF1A Q16665 1/20 0.48
▸ BHMT Q93088 5/20 0.47
▸ ARG1 P05089 1/20 0.38
▸ ARG2 P78540 1/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ NOS2 P35228 4/20 0.38
▸ NOS1 P29475 2/20 0.38
▸ NOS3 P29474 1/20 0.38
▸ BLM P54132 2/20 0.38
▸ GMNN O75496 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ CYP1A2 P05177 2/20 0.33
▸ GRM8 O00222 1/20 0.33
▸ GRM6 O15303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16087209 1.00 CYP2D6 (0.48) CYP2D6HIF1ABHMTARG1ARG2
SCHEMBL21955443 0.86 ARG1 (0.36) BHMTARG1ARG2CYP2C19NOS2
Carbocysteine SCHEMBL20854 0.84 BHMT (0.59) CYP2D6HIF1ABHMTARG1ARG2
SCHEMBL15765931 0.84 ARG1 (0.35) BHMTARG1ARG2NOS2NOS1
Carbocysteine SCHEMBL69149 0.84 BHMT (0.59) CYP2D6HIF1ABHMTARG1ARG2
Carbocysteine SCHEMBL6762355 0.84 BHMT (0.59) CYP2D6HIF1ABHMTARG1ARG2
Carbocysteine SCHEMBL9236855 0.84 BHMT (0.59) CYP2D6HIF1ABHMTARG1ARG2
Carbocysteine SCHEMBL15545269 0.82 BHMT (0.57) CYP2D6HIF1ABHMTARG1ARG2
Carbocysteine SCHEMBL19614507 0.82 BHMT (0.57) CYP2D6HIF1ABHMTARG1ARG2
Carbocysteine SCHEMBL15546452 0.82 BHMT (0.57) CYP2D6HIF1ABHMTARG1ARG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2398483-B1 OXYNTOMODULIN ANALOGS MERCK SHARP & DOHME (US) 2014-09-24 — — EP disclosed
US-6086881-A FOR USE AS AN IMMUNOGEN OR VACCINE; COMPRISING HAPTENS OR ANTIGENS FROM CHOSEN INFECTIOUS AGENT, AND CHEMICALLY SUBSTITUTED METALLIC OXIDE NANOPARTICLES COUPLED VIA THIOETHER BOND TO THE HAPTENS OR ANTIGENS CHILDREN'S MEDICAL CENTER CORP. (US) 2000-07-11 — — US disclosed
Send feedback